154 related articles for article (PubMed ID: 9753245)
1. Nonopsonic activation of neutrophils by Helicobacter pylori is inhibited by rebamipide.
Danielsson D; Jurstrand M
Dig Dis Sci; 1998 Sep; 43(9 Suppl):167S-173S. PubMed ID: 9753245
[TBL] [Abstract][Full Text] [Related]
2. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
[TBL] [Abstract][Full Text] [Related]
3. Rebamipide protects against activation of neutrophils by Helicobacter pylori.
Yoshida N; Yoshikawa T; Iinuma S; Arai M; Takenaka S; Sakamoto K; Miyajima T; Nakamura Y; Yagi N; Naito Y; Mukai F; Kondo M
Dig Dis Sci; 1996 Jun; 41(6):1139-44. PubMed ID: 8654144
[TBL] [Abstract][Full Text] [Related]
4. The antioxidant effect of rebamipide on oxygen free radical production by H. pylori-activated human neutrophils: in comparison with N-acetylcysteine, ascorbic acid and glutathione.
Hong WS; Jung HY; Yang SK; Myung SJ; Kim JH; Min YI; Chung MH; Lee HS; Kim HW
Pharmacol Res; 2001 Oct; 44(4):293-7. PubMed ID: 11592863
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of attenuating effects of rebamipide, an anti-ulcer agent, on oxidative burst of human neutrophils.
Shimoyama T; Fukuda S; Liu Q; Fukuda Y; Nakaji S; Sugawara K
J Pharmacol Sci; 2003 Feb; 91(2):153-7. PubMed ID: 12686760
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies indicating antioxidative properties of rebamipide.
Iinuma S; Naito Y; Yoshikawa T; Takahashi S; Takemura T; Yoshida N; Kondo M
Dig Dis Sci; 1998 Sep; 43(9 Suppl):35S-39S. PubMed ID: 9753224
[TBL] [Abstract][Full Text] [Related]
7. Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils.
Han BG; Kim HS; Rhee KH; Han HS; Chung MH
Pharmacol Res; 1995 Oct; 32(4):201-7. PubMed ID: 8866835
[TBL] [Abstract][Full Text] [Related]
8. The effect of rebamipide on the expression of proinflammatory mediators and apoptosis in human neutrophils by Helicobacter pylori water-soluble surface proteins.
Kim JS; Kim JM; Jung HC; Song IS
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():45-54. PubMed ID: 12925140
[TBL] [Abstract][Full Text] [Related]
9. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of rebamipide on the neutrophil adherence stimulated by conditioned media from Helicobacter pylori-infected gastric epithelial cells.
Kim CD; Kim HH; Hong KW
J Pharmacol Exp Ther; 1999 Jan; 288(1):133-8. PubMed ID: 9862763
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines.
Aihara M; Azuma A; Takizawa H; Tsuchimoto D; Funakoshi Y; Shindo Y; Ohmoto Y; Imagawa K; Kikuchi M; Mukaida N; Matsushima K
Dig Dis Sci; 1998 Sep; 43(9 Suppl):174S-180S. PubMed ID: 9753246
[TBL] [Abstract][Full Text] [Related]
12. Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
Masamune A; Yoshida M; Sakai Y; Shimosegawa T
J Pharmacol Exp Ther; 2001 Aug; 298(2):485-92. PubMed ID: 11454909
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nonopsonic Helicobacter pylori-induced activation of human neutrophils by sialylated oligosaccharides.
Teneberg S; Jurstrand M; Karlsson KA; Danielsson D
Glycobiology; 2000 Nov; 10(11):1171-81. PubMed ID: 11087709
[TBL] [Abstract][Full Text] [Related]
14. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.
Hayashi S; Sugiyama T; Amano K; Isogai H; Isogai E; Aihara M; Kikuchi M; Asaka M; Yokota K; Oguma K; Fujii N; Hirai Y
Antimicrob Agents Chemother; 1998 Aug; 42(8):1895-9. PubMed ID: 9687380
[TBL] [Abstract][Full Text] [Related]
15. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing.
Arakawa T; Kobayashi K; Yoshikawa T; Tarnawski A
Dig Dis Sci; 1998 Sep; 43(9 Suppl):5S-13S. PubMed ID: 9753220
[TBL] [Abstract][Full Text] [Related]
16. Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.
Watanabe T; Higuchi K; Hamaguchi M; Tanigawa T; Wada R; Tominaga K; Fujiwara Y; Arakawa T
Dig Dis Sci; 2002 Jul; 47(7):1582-9. PubMed ID: 12141820
[TBL] [Abstract][Full Text] [Related]
17. [Rebamipide].
Shimoyama T; Fukuda S; Liu Q; Sugawara K
Nihon Rinsho; 2002 Feb; 60 Suppl 2():698-703. PubMed ID: 11979874
[No Abstract] [Full Text] [Related]
18. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats.
Murakami K; Okajima K; Harada N; Isobe H; Okabe H
Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240
[TBL] [Abstract][Full Text] [Related]
19. Preventive effect of rebamipide on gastric mucosal cell damage evoked by activation of formyl-methionyl-leucyl-phenylalanine receptors of rabbit neutrophils.
Kim CD; Hong KW
J Pharmacol Exp Ther; 1997 Apr; 281(1):478-83. PubMed ID: 9103534
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of lipid peroxidation, NF-kappaB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells.
Kim H; Seo JY; Kim KH
Dig Dis Sci; 2000 Mar; 45(3):621-8. PubMed ID: 10749342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]